SRHU distributes Nutritional Kits to 77 TB Patients under the PM’s TB eradication initiative

Published on: August 28, 2023

SRHU distributes Nutritional Kits to 77 TB Patients under the PM’s TB eradication initiative

SRHU Jollygrant distributed nutritional kits to 77 TB patients under the TB Free India campaign.

It may be recalled that 600 patients had been adopted by SRHU earlier in the year.

With the assistance of AS Foundation, SRHU is providing treatment, examination, and nourishment for a year to these patients.

Nutritional kits were distributed to 77 TB patients in CHC Bahadrabad, Haridwar, under the initiative of Swami Rama Himalayan University (SRHU).

Chancellor Dr. Vijay Dhasmana informed that SRHU Jollygrant, on behalf of the Prime Minister’s TB-Free India Campaign, has adopted 600 TB patients. The University and the institution are aiding in examination and treatment of these patients by providing them nutritional kits each month. The institution aims to adopt 1000 TB patients in the future.

The Community Medicine Department of SRHU, Gramya Vikas Sansthan, and the Chest and Respiratory Department of Himalayan Hospital Jollygrant, in collaboration with AS Foundation, have joined hands in implementing this initiative.

Nutritional kits were handed over to 77 TB patients in CHC Bahadrabad. The TB eradication programme has pressed into service the services of ASHA workers for distributing the kits and conducting health checks.

The kits include lentils, porridge, semolina, eggs, peanuts, and milk, among other nutritious items.

Dr. Anil Bisht, Dr. Shivam, Dr. Afzal, and Dr. Yogesh from the Community Medicine Department examined the patients.

Since June, selected ASHA workers {TB patients} in Doiwala Block, Rishikesh area, and Bahadrabad Block area have been receiving monthly nutritional meals provided by the institution. Neelam Pandey supervised the program. AS Foundation’s Hemlata sister, Alisha, Sugandha, Pawan Deep Kaur, Anil Negi, District Coordinator Haridwar {TB Program}, Sudhir, Parul, Savita, Tina, Himanshu, Sanjogita, and others have made significant contributions.

2-1.jpg
3-1.jpg
1-1.jpg
   Admissions Form         

Admission Open For 2025

×
International Endowed Chair Professor

Prof Rakesh Kumar

Prof Rakesh Kumar is the Founder and President of the Breast Cancer in Young Women Foundation (USA), dedicated to vaddressing the distinct issues affecting young women with breast cancer. He also serves as the International Endowed Chair Professor at the Cancer Research Institute of the Himalayan Institute of Medical Sciences. Additionally, he holds adjunct professorships at Rutgers New Jersey Medical School and Virginia Commonwealth University.

Dr Kumar earned his Ph.D. from the All India Institute of Medical Sciences in 1984 and began his research career at Memorial Sloan Kettering Cancer Center in January 1986. From 1988 to 2017, he held various academic and leadership positions —including faculty member, tenured professor, distinguished professor, endowed chair, department chair, and research leader—at esteemed institutions such as Memorial Sloan Kettering Cancer Center in New York and the University of Texas MD Anderson Cancer Center in Houston. From 2017 to 2022, he served as the National Chair for Cancer Research for the Government of India and as a distinguished professor, continuing his innovative work in breast cancer research.

With nearly 40 years of research and professional experience, Dr. Kumar has made conceptual contributions to the field of cancer research (h-index 108, citations >50,000). He has authored over 325 peer-reviewed publications, edited or co-edited nine books, and delivered 290 invited lectures worldwide. His work has been featured on the covers of 18 major cancer journals and has been highlighted in institutional research reports of the MD Anderson Cancer Center.

A passionate educator and mentor, Dr. Kumar has guided 67 trainees throughout his career. He serves on the editorial boards of multiple leading cancer journals and has served on the editorial boards of 21 top cancer journals. His global reputation is further demonstrated by his participation in about 100 peer-review panels for cancer research funding in the US and internationally over the past 28 years.

Dr. Kumar's innovative research has earned him numerous prestigious honors, including the Hinkle Society Faculty Award at Penn State University (1994), the Dalla/Fort Worth Living Legend Faculty Achievement Award in Basic Sciences (2004), the Ranbaxy Research Award (2006), and the Lifetime Achievement Award from the American Association of Indian Scientists in Cancer Research (2013), among others. Dr. Kumar's pioneering research continues to have a profound influence on the fields of oncology and breast cancer, opening up new opportunities for biomedical scientists and trainees worldwide.